evidence card · weight_loss_cardiometabolic
Clinically meaningful weight loss improves cardiometabolic risk factors
H5
▲ supports
stakes high
8 posts scored
·
across 5 accounts
·
2 sources
Summary
DiRECT, Look AHEAD (biomarkers), GLP-1 RA trials. Very consistent signal on surrogates; mortality evidence strongest for GLP-1 RA in high-risk groups.
Five-score assessment
Scores not yet assigned for this card. (Legacy card; will be populated on next refinement.)
Scope
Population
adults with overweight or obesity
Intervention
weight loss of 5%+
Outcome
BP, glycemia, lipids, hepatic steatosis
Not supported for
- guaranteed mortality reduction from any weight loss
Evidence sources
Sources
-
guideline USPSTF Weight Loss Interventions ↗